NDC 61703-349 – Irinotecan Hydrochloride
Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Intravenous
Product NDC61703-349
Product details
- Brand name
- Irinotecan Hydrochloride
- Generic name
- Irinotecan Hydrochloride
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA077915
- Marketed since
- February 27, 2008
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Irinotecan Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Irinotecan Hydrochloride →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 61703-349-09 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-09) / 5 mL in 1 VIAL, SINGLE-DOSE | Feb 27, 2008 |
| 61703-349-16 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-16) / 2 mL in 1 VIAL, SINGLE-DOSE | Feb 27, 2008 |
| 61703-349-36 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-36) / 25 mL in 1 VIAL, SINGLE-DOSE | Feb 27, 2008 |
Other Irinotecan Hydrochloride products
- 45963-614 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 60505-6272 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 60505-6128 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 55150-355 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-354 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-353 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-352 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 63323-193 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-382 Irinotecan Hydrochloride 20 mg/mL · Injection · Gland Pharma Limited
- 0143-9701 Irinotecan Hydrochloride 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9702 Irinotecan Hydrochloride 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9583 Irinotecan Hydrochloride 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.